LM N°2/ 2024. What is the state of hyaluronic acid R&D, today and tomorrow? Michel CHERON PDt and CEO of the VIVACY Group Interview by Pr AC BENHAMOU
Hyaluronic acid is at the heart of your industrial research and the development of medical applications for hyaluronic acid. Can you tell us about Vivacy's current development in this sector?
LM N°2/ 2024. AH'S FLAGSHIP CLINICAL APPLICATIONS. Aesthetic and functional health in gynecology and HA. Les Entretiens de L&M: Interview with Pr Pierre MARES. MULTIPOINT VAGINAL INJECTIONS OF CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF MENOPAUSAL GENITOURINARY SYNDROME (MGUS) ASSOCIATED WITH VULVOVAGINAL ATROPHY (VVA).
AH'S FLAGSHIP CLINICAL APPLICATIONS. Aesthetic and functional health in gynecology and HA. Les Entretiens de L&M: Interview with Pr Pierre MARES. MULTIPOINT VAGINAL INJECTIONS OF CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF MENOPAUSAL GENITOURINARY SYNDROME (MGUS) ASSOCIATED WITH VULVOVAGINAL ATROPHY (VVA). Key words: dryness, dyspareunia, hyaluronic acid, menopause, [...]